Kircik L, Lebwohl M, Papp K, Gooderham M, Stein Gold L, Draelos Z, Kempers S, Tyring S, Albrecht L, Wiseman M, Ferris L, Smith K, Higham R, Navale L, Welgus H, Berk D. Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study. J of Skin [Internet]. 2020 Oct. 27 [cited 2024 Jul. 1];4(6):s70. Available from: https://jofskin.org/33014/index.php/skin/article/view/1103